BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 33416070)

  • 1. Antidiabetic Potential of Tea and Its Active Compounds: From Molecular Mechanism to Clinical Evidence.
    Wei Y; Shao J; Pang Y; Wen C; Wei K; Peng L; Wang Y; Wei X
    J Agric Food Chem; 2024 May; 72(21):11837-11853. PubMed ID: 38743877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Potential Plant-Derived Pancreatic Beta-Cell-Directed Agents Using New Custom-Designed Screening Method:
    Al-Romaiyan A; Persaud SJ; Jones PM
    Molecules; 2023 Dec; 29(1):. PubMed ID: 38202777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs.
    Olatunde A; Nigam M; Singh RK; Panwar AS; Lasisi A; Alhumaydhi FA; Jyoti Kumar V; Mishra AP; Sharifi-Rad J
    Cancer Cell Int; 2021 Sep; 21(1):499. PubMed ID: 34535145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant, Anti-Diabetic, and Anti-Inflammation Activity of
    Nethengwe M; Kerebba N; Okaiyeto K; Opuwari CS; Oguntibeju OO
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translation of preclinical ethnomedicine data in LMICs: the example of rooibos.
    Pretorius L; Smith C
    Front Pharmacol; 2023; 14():1328828. PubMed ID: 38174224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UPLC-ESI-QTOF-MS Profiling of Phenolic Compounds from
    Okaiyeto K; Kerebba N; Oguntibeju OO
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36558046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coumarin-based Scaffold as α-glucosidase Inhibitory Activity: Implication for the Development of Potent Antidiabetic Agents.
    Tafesse TB; Bule MH; Khoobi M; Faramarzi MA; Abdollahi M; Amini M
    Mini Rev Med Chem; 2020; 20(2):134-151. PubMed ID: 31553294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspalathin from Rooibos (Aspalathus linearis): A Bioactive C-glucosyl Dihydrochalcone with Potential to Target the Metabolic Syndrome.
    Johnson R; Beer D; Dludla PV; Ferreira D; Muller CJF; Joubert E
    Planta Med; 2018 Jul; 84(9-10):568-583. PubMed ID: 29388183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of palmitate-induced insulin resistance in C₂C₁₂ muscle cells by rooibos (Aspalathus linearis).
    Mazibuko SE; Muller CJ; Joubert E; de Beer D; Johnson R; Opoku AR; Louw J
    Phytomedicine; 2013 Jul; 20(10):813-9. PubMed ID: 23639187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute assessment of an aspalathin-enriched green rooibos (Aspalathus linearis) extract with hypoglycemic potential.
    Muller CJ; Joubert E; de Beer D; Sanderson M; Malherbe CJ; Fey SJ; Louw J
    Phytomedicine; 2012 Dec; 20(1):32-9. PubMed ID: 23083813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cardioprotective effect of an aqueous extract of fermented rooibos (Aspalathus linearis) on cultured cardiomyocytes derived from diabetic rats.
    Dludla PV; Muller CJ; Louw J; Joubert E; Salie R; Opoku AR; Johnson R
    Phytomedicine; 2014 Apr; 21(5):595-601. PubMed ID: 24268738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Z-2-(β-D-glucopyranosyloxy)-3-phenylpropenoic acid, an α-hydroxy acid from rooibos (Aspalathus linearis) with hypoglycemic activity.
    Muller CJ; Joubert E; Pheiffer C; Ghoor S; Sanderson M; Chellan N; Fey SJ; Louw J
    Mol Nutr Food Res; 2013 Dec; 57(12):2216-22. PubMed ID: 23943314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fermented rooibos (Aspalathus linearis) on adipocyte differentiation.
    Sanderson M; Mazibuko SE; Joubert E; de Beer D; Johnson R; Pheiffer C; Louw J; Muller CJ
    Phytomedicine; 2014 Jan; 21(2):109-17. PubMed ID: 24060217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive
    Pringle NA; van de Venter M; Koekemoer TC
    Food Funct; 2021 Feb; 12(3):1020-1038. PubMed ID: 33416070
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.